Back
Blueprint Medicines Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
25
BPMC
Blueprint Medicines
Last Price:
$90.40
Seasonality Move:
2.18%
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 92.09 | Sell |
| 20-day SMA: | 94.08 | Sell |
| 50-day SMA: | 92.47 | Sell |
| 200-day SMA: | 96.71 | Sell |
| 8-day EMA: | 91.64 | Sell |
| 20-day EMA: | 93.02 | Sell |
| 50-day EMA: | 93.13 | Sell |
| 200-day EMA: | 91.72 | Sell |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.83 | Sell |
| Relative Strength Index (14 RSI): | 42.96 | Sell |
| Chaikin Money Flow: | 68158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.96 - 96.5) | Sell |
| Bollinger Bands (100): | (87.57 - 95.87) | Sell |
Blueprint Medicines Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 90.46 while BPMC 8-day simple moving average is 92.09, which is a Sell signal.
-
The stock price of BPMC is 90.46 while Blueprint Medicines 20-day SMA is 94.08, which makes it a Sell.
-
Blueprint Medicines 50-day simple moving average is 92.47 while BPMC share price is 90.46, making it a Sell technically.
-
BPMC stock price is 90.46 and Blueprint Medicines 200-day simple moving average is 96.71, creating a Sell signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
25
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a SellThe current Blueprint Medicines [BPMC] share price is $90.46. The Score for BPMC is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
5.7B
Price in USD:
90.46
Share Volume:
113.6K
Blueprint Medicines 52-Week Range
52-Week High:
121.90
52-Week Low:
72.24
Sell
25
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 90.46 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 90.46 while BPMC 8-day exponential moving average is 91.64, which is a Sell signal.
-
The stock price of BPMC is 90.46 while Blueprint Medicines 20-day EMA is 93.02, which makes it a Sell.
-
Blueprint Medicines 50-day exponential moving average is 93.13 while BPMC share price is 90.46, making it a Sell technically.
-
BPMC stock price is 90.46 and Blueprint Medicines 200-day simple moving average is 91.72, creating a Sell signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is -0.83, suggesting Blueprint Medicines is a Sell
-
Blueprint Medicines Relative Strength Index (RSI) is 42.96, which suggest Blueprint Medicines is oversold
-
The Bollinger Bands (25) for Blueprint Medicines is (91.96 - 96.5), which suggest Blueprint Medicines is a Sell
-
The Bollinger Bands (100) for Blueprint Medicines is (87.57 - 95.87), which suggest Blueprint Medicines is a Sell
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.